Global Neurofeedback Market

Neurofeedback Comprehensive Study by Type (Traditional Neurofeedback, QEEG Loreta Neurofeedback), Application (Neurocare Clinics, Hospitals, Training Institutes, Scientific Research, Others), Function (Sleep Management, Emotional Regulation, Mental Fitness), Component (EEG Sensor, System, Software), System (Slow Cortical Potential Neurofeedback (SCP-NF), Low-energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), Functional Magnetic Resonance Imaging (fMRI), Other) Players and Region - Global Market Outlook to 2030

Neurofeedback Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Neurofeedback Market Scope
Neurofeedback is also known as EEG (electroencephalogram) biofeedback which is a non-invasive method of direct brain function training. It is a therapeutic intervention that provides immediate feedback from a computer program by assessing a person's brainwave activity. It uses the electrodes (act as a microphone) or headband with sensors placed on the scalp which records the EEG and control auditory, visual signals and all these responses are recorded by making them watch a movie to check their brain activity (emotional activity and responses) as to how their brain is responding. On the basis of this method, the mental professionals make the diagnosis, the cause, and its treatment.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledNeuro Care Group (Germany), Myndlift Ltd (Israel), Brainmaster Technologies, Inc. (United States), Mitsar Co. Ltd (Russia), Emotiv Inc. (United States), Brainworks (United States), Mindfield Biosystems Ltd. (United Kingdom), Narbis (United States), Thought Technology Ltd. (Canada), InteraXon Inc. (Muse) (Canada), Mind Media (Netherlands) and NeuralScan (United States)
CAGR%


The Neurofeedback market is highly competitive but only in some regions. The players of the Neurofeedback market are planning to expand their market and service geographically by investing in research and development. They are organizing various programs so as to spread awareness about mental health and other issues. The companies are also focusing on the expansion of their product portfolio such as software systems, headbands required in the therapy which will maintain their competitive edge in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Neurofeedback market throughout the predicted period.

Neuro Care Group (Germany), Myndlift Ltd (Israel), Brainmaster Technologies, Inc. (United States), Mitsar Co. Ltd (Russia), Emotiv Inc. (United States), Brainworks (United States), Mindfield Biosystems Ltd. (United Kingdom), Narbis (United States), Thought Technology Ltd. (Canada), InteraXon Inc. (Muse) (Canada), Mind Media (Netherlands) and NeuralScan (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Wearable Sensing (United States), Stens Corporation (United States) and BEE Medic (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Neurofeedback market by Type , by Application (Neurocare Clinics, Hospitals, Training Institutes, Scientific Research and Others) and Region with country level break-up.

On the basis of geography, the market of Neurofeedback has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In July 2020, Children acquire language through an informal process of exposure to language and social interactions. This process Learning a language through listening to others speak is referred to as auditory perceptual learning. Reading to and speaking with children helps them to recognize and differentiate sounds
In October 2019, Narbis announced the launch of the online availability of its proprietary Narbi smart glasses that use principles of neurofeedback and algorithm developed by NASA to eliminate distractibility and helps in concentration while reading, studying, working on the computer or doing homework. The company uses neurofeedback with a penalty and reward model based on brain patterns called operant conditioning. Narbis’ technology requires only three sensors—one behind each ear and one on top of the head—and an app powered by a NASA algorithm to track relaxation, distraction, and focus. When distracted, the glasses darken. When relaxed and concentrating, the glasses instantly clear.
"Before using any biofeedback device for clinical purposes, the provider must be certain that it is registered with the FDA. An FDA registered device may not be labeled for the application the therapist intends to use it for. If the device is not labeled for the disorder to be treated, the provider is must inform the client – in writing - that the provider proposes to use the device “off label” and the client must agree in writing."

Influencing Trend:
The Emergence of Wearable Technology for Neurofeedback and Emerging Use of Neurofeedback Therapy on Children to Enhance the Mental Fitness

Market Growth Drivers:
Increasing prevalence of anxiety, ADHD, and depression in people across the world leading to other problems like insomnia. It needs to be managed, regulated for emotional wellbeing resulting in better sleep management.

Challenges:
Technical Problems with Systems and Softwares used in Neurofeedback and Less Number of Licensed Mental Health Professionals

Restraints:
Expensive Neurofeedback Session Might be the Hindrance for the Market and Risk of Side Effects Associated with Neurofeedback Medication

Opportunities:
Introduction of Various Family Welfare Programs Regarding Neurofeedback and its Benefits and Awareness About Mental Health and Fitness

Key Target Audience
Neurofeedback Therapy Providers, Neurofeedback System Manufacturers, Neurofeedback Software Developers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Psychologists, Hospitals and Others

Report Objectives / Segmentation Covered

By Type
  • Traditional Neurofeedback
  • QEEG Loreta Neurofeedback
By Application
  • Neurocare Clinics
  • Hospitals
  • Training Institutes
  • Scientific Research
  • Others
By Function
  • Sleep Management
  • Emotional Regulation
  • Mental Fitness

By Component
  • EEG Sensor
  • System
  • Software

By System
  • Slow Cortical Potential Neurofeedback (SCP-NF)
  • Low-energy Neurofeedback System (LENS)
  • Hemoencephalographic (HEG) Neurofeedback
  • Live Z-Score Neurofeedback System
  • Low-Resolution Electromagnetic Tomography (LORE-TA)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of anxiety, ADHD, and depression in people across the world leading to other problems like insomnia. It needs to be managed, regulated for emotional wellbeing resulting in better sleep management.
    • 3.3. Market Challenges
      • 3.3.1. Technical Problems with Systems and Softwares used in Neurofeedback
      • 3.3.2. Less Number of Licensed Mental Health Professionals
    • 3.4. Market Trends
      • 3.4.1. The Emergence of Wearable Technology for Neurofeedback
      • 3.4.2. Emerging Use of Neurofeedback Therapy on Children to Enhance the Mental Fitness
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neurofeedback, by Type, Application, Function, Component, System and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Neurofeedback (Value)
      • 5.2.1. Global Neurofeedback by: Type (Value)
        • 5.2.1.1. Traditional Neurofeedback
        • 5.2.1.2. QEEG Loreta Neurofeedback
      • 5.2.2. Global Neurofeedback by: Application (Value)
        • 5.2.2.1. Neurocare Clinics
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Training Institutes
        • 5.2.2.4. Scientific Research
        • 5.2.2.5. Others
      • 5.2.3. Global Neurofeedback by: Function (Value)
        • 5.2.3.1. Sleep Management
        • 5.2.3.2. Emotional Regulation
        • 5.2.3.3. Mental Fitness
      • 5.2.4. Global Neurofeedback by: Component (Value)
        • 5.2.4.1. EEG Sensor
        • 5.2.4.2. System
        • 5.2.4.3. Software
      • 5.2.5. Global Neurofeedback by: System (Value)
        • 5.2.5.1. Slow Cortical Potential Neurofeedback (SCP-NF)
        • 5.2.5.2. Low-energy Neurofeedback System (LENS)
        • 5.2.5.3. Hemoencephalographic (HEG) Neurofeedback
        • 5.2.5.4. Live Z-Score Neurofeedback System
        • 5.2.5.5. Low-Resolution Electromagnetic Tomography (LORE-TA)
        • 5.2.5.6. Functional Magnetic Resonance Imaging (fMRI)
        • 5.2.5.7. Other
      • 5.2.6. Global Neurofeedback Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Neurofeedback: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Neuro Care Group (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Myndlift Ltd (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Brainmaster Technologies, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mitsar Co. Ltd (Russia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Emotiv Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Brainworks (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mindfield Biosystems Ltd. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Narbis (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thought Technology Ltd. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. InteraXon Inc. (Muse) (Canada)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Mind Media (Netherlands)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. NeuralScan (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Neurofeedback Sale, by Type, Application, Function, Component, System and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Neurofeedback (Value)
      • 7.2.1. Global Neurofeedback by: Type (Value)
        • 7.2.1.1. Traditional Neurofeedback
        • 7.2.1.2. QEEG Loreta Neurofeedback
      • 7.2.2. Global Neurofeedback by: Application (Value)
        • 7.2.2.1. Neurocare Clinics
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Training Institutes
        • 7.2.2.4. Scientific Research
        • 7.2.2.5. Others
      • 7.2.3. Global Neurofeedback by: Function (Value)
        • 7.2.3.1. Sleep Management
        • 7.2.3.2. Emotional Regulation
        • 7.2.3.3. Mental Fitness
      • 7.2.4. Global Neurofeedback by: Component (Value)
        • 7.2.4.1. EEG Sensor
        • 7.2.4.2. System
        • 7.2.4.3. Software
      • 7.2.5. Global Neurofeedback by: System (Value)
        • 7.2.5.1. Slow Cortical Potential Neurofeedback (SCP-NF)
        • 7.2.5.2. Low-energy Neurofeedback System (LENS)
        • 7.2.5.3. Hemoencephalographic (HEG) Neurofeedback
        • 7.2.5.4. Live Z-Score Neurofeedback System
        • 7.2.5.5. Low-Resolution Electromagnetic Tomography (LORE-TA)
        • 7.2.5.6. Functional Magnetic Resonance Imaging (fMRI)
        • 7.2.5.7. Other
      • 7.2.6. Global Neurofeedback Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neurofeedback: by Type(USD Million)
  • Table 2. Neurofeedback Traditional Neurofeedback , by Region USD Million (2018-2023)
  • Table 3. Neurofeedback QEEG Loreta Neurofeedback , by Region USD Million (2018-2023)
  • Table 4. Neurofeedback: by Application(USD Million)
  • Table 5. Neurofeedback Neurocare Clinics , by Region USD Million (2018-2023)
  • Table 6. Neurofeedback Hospitals , by Region USD Million (2018-2023)
  • Table 7. Neurofeedback Training Institutes , by Region USD Million (2018-2023)
  • Table 8. Neurofeedback Scientific Research , by Region USD Million (2018-2023)
  • Table 9. Neurofeedback Others , by Region USD Million (2018-2023)
  • Table 10. Neurofeedback: by Function(USD Million)
  • Table 11. Neurofeedback Sleep Management , by Region USD Million (2018-2023)
  • Table 12. Neurofeedback Emotional Regulation , by Region USD Million (2018-2023)
  • Table 13. Neurofeedback Mental Fitness , by Region USD Million (2018-2023)
  • Table 14. Neurofeedback: by Component(USD Million)
  • Table 15. Neurofeedback EEG Sensor , by Region USD Million (2018-2023)
  • Table 16. Neurofeedback System , by Region USD Million (2018-2023)
  • Table 17. Neurofeedback Software , by Region USD Million (2018-2023)
  • Table 18. Neurofeedback: by System(USD Million)
  • Table 19. Neurofeedback Slow Cortical Potential Neurofeedback (SCP-NF) , by Region USD Million (2018-2023)
  • Table 20. Neurofeedback Low-energy Neurofeedback System (LENS) , by Region USD Million (2018-2023)
  • Table 21. Neurofeedback Hemoencephalographic (HEG) Neurofeedback , by Region USD Million (2018-2023)
  • Table 22. Neurofeedback Live Z-Score Neurofeedback System , by Region USD Million (2018-2023)
  • Table 23. Neurofeedback Low-Resolution Electromagnetic Tomography (LORE-TA) , by Region USD Million (2018-2023)
  • Table 24. Neurofeedback Functional Magnetic Resonance Imaging (fMRI) , by Region USD Million (2018-2023)
  • Table 25. Neurofeedback Other , by Region USD Million (2018-2023)
  • Table 26. South America Neurofeedback, by Country USD Million (2018-2023)
  • Table 27. South America Neurofeedback, by Type USD Million (2018-2023)
  • Table 28. South America Neurofeedback, by Application USD Million (2018-2023)
  • Table 29. South America Neurofeedback, by Function USD Million (2018-2023)
  • Table 30. South America Neurofeedback, by Component USD Million (2018-2023)
  • Table 31. South America Neurofeedback, by System USD Million (2018-2023)
  • Table 32. Brazil Neurofeedback, by Type USD Million (2018-2023)
  • Table 33. Brazil Neurofeedback, by Application USD Million (2018-2023)
  • Table 34. Brazil Neurofeedback, by Function USD Million (2018-2023)
  • Table 35. Brazil Neurofeedback, by Component USD Million (2018-2023)
  • Table 36. Brazil Neurofeedback, by System USD Million (2018-2023)
  • Table 37. Argentina Neurofeedback, by Type USD Million (2018-2023)
  • Table 38. Argentina Neurofeedback, by Application USD Million (2018-2023)
  • Table 39. Argentina Neurofeedback, by Function USD Million (2018-2023)
  • Table 40. Argentina Neurofeedback, by Component USD Million (2018-2023)
  • Table 41. Argentina Neurofeedback, by System USD Million (2018-2023)
  • Table 42. Rest of South America Neurofeedback, by Type USD Million (2018-2023)
  • Table 43. Rest of South America Neurofeedback, by Application USD Million (2018-2023)
  • Table 44. Rest of South America Neurofeedback, by Function USD Million (2018-2023)
  • Table 45. Rest of South America Neurofeedback, by Component USD Million (2018-2023)
  • Table 46. Rest of South America Neurofeedback, by System USD Million (2018-2023)
  • Table 47. Asia Pacific Neurofeedback, by Country USD Million (2018-2023)
  • Table 48. Asia Pacific Neurofeedback, by Type USD Million (2018-2023)
  • Table 49. Asia Pacific Neurofeedback, by Application USD Million (2018-2023)
  • Table 50. Asia Pacific Neurofeedback, by Function USD Million (2018-2023)
  • Table 51. Asia Pacific Neurofeedback, by Component USD Million (2018-2023)
  • Table 52. Asia Pacific Neurofeedback, by System USD Million (2018-2023)
  • Table 53. China Neurofeedback, by Type USD Million (2018-2023)
  • Table 54. China Neurofeedback, by Application USD Million (2018-2023)
  • Table 55. China Neurofeedback, by Function USD Million (2018-2023)
  • Table 56. China Neurofeedback, by Component USD Million (2018-2023)
  • Table 57. China Neurofeedback, by System USD Million (2018-2023)
  • Table 58. Japan Neurofeedback, by Type USD Million (2018-2023)
  • Table 59. Japan Neurofeedback, by Application USD Million (2018-2023)
  • Table 60. Japan Neurofeedback, by Function USD Million (2018-2023)
  • Table 61. Japan Neurofeedback, by Component USD Million (2018-2023)
  • Table 62. Japan Neurofeedback, by System USD Million (2018-2023)
  • Table 63. India Neurofeedback, by Type USD Million (2018-2023)
  • Table 64. India Neurofeedback, by Application USD Million (2018-2023)
  • Table 65. India Neurofeedback, by Function USD Million (2018-2023)
  • Table 66. India Neurofeedback, by Component USD Million (2018-2023)
  • Table 67. India Neurofeedback, by System USD Million (2018-2023)
  • Table 68. South Korea Neurofeedback, by Type USD Million (2018-2023)
  • Table 69. South Korea Neurofeedback, by Application USD Million (2018-2023)
  • Table 70. South Korea Neurofeedback, by Function USD Million (2018-2023)
  • Table 71. South Korea Neurofeedback, by Component USD Million (2018-2023)
  • Table 72. South Korea Neurofeedback, by System USD Million (2018-2023)
  • Table 73. Taiwan Neurofeedback, by Type USD Million (2018-2023)
  • Table 74. Taiwan Neurofeedback, by Application USD Million (2018-2023)
  • Table 75. Taiwan Neurofeedback, by Function USD Million (2018-2023)
  • Table 76. Taiwan Neurofeedback, by Component USD Million (2018-2023)
  • Table 77. Taiwan Neurofeedback, by System USD Million (2018-2023)
  • Table 78. Australia Neurofeedback, by Type USD Million (2018-2023)
  • Table 79. Australia Neurofeedback, by Application USD Million (2018-2023)
  • Table 80. Australia Neurofeedback, by Function USD Million (2018-2023)
  • Table 81. Australia Neurofeedback, by Component USD Million (2018-2023)
  • Table 82. Australia Neurofeedback, by System USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Neurofeedback, by Type USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Neurofeedback, by Application USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Neurofeedback, by Function USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Neurofeedback, by Component USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Neurofeedback, by System USD Million (2018-2023)
  • Table 88. Europe Neurofeedback, by Country USD Million (2018-2023)
  • Table 89. Europe Neurofeedback, by Type USD Million (2018-2023)
  • Table 90. Europe Neurofeedback, by Application USD Million (2018-2023)
  • Table 91. Europe Neurofeedback, by Function USD Million (2018-2023)
  • Table 92. Europe Neurofeedback, by Component USD Million (2018-2023)
  • Table 93. Europe Neurofeedback, by System USD Million (2018-2023)
  • Table 94. Germany Neurofeedback, by Type USD Million (2018-2023)
  • Table 95. Germany Neurofeedback, by Application USD Million (2018-2023)
  • Table 96. Germany Neurofeedback, by Function USD Million (2018-2023)
  • Table 97. Germany Neurofeedback, by Component USD Million (2018-2023)
  • Table 98. Germany Neurofeedback, by System USD Million (2018-2023)
  • Table 99. France Neurofeedback, by Type USD Million (2018-2023)
  • Table 100. France Neurofeedback, by Application USD Million (2018-2023)
  • Table 101. France Neurofeedback, by Function USD Million (2018-2023)
  • Table 102. France Neurofeedback, by Component USD Million (2018-2023)
  • Table 103. France Neurofeedback, by System USD Million (2018-2023)
  • Table 104. Italy Neurofeedback, by Type USD Million (2018-2023)
  • Table 105. Italy Neurofeedback, by Application USD Million (2018-2023)
  • Table 106. Italy Neurofeedback, by Function USD Million (2018-2023)
  • Table 107. Italy Neurofeedback, by Component USD Million (2018-2023)
  • Table 108. Italy Neurofeedback, by System USD Million (2018-2023)
  • Table 109. United Kingdom Neurofeedback, by Type USD Million (2018-2023)
  • Table 110. United Kingdom Neurofeedback, by Application USD Million (2018-2023)
  • Table 111. United Kingdom Neurofeedback, by Function USD Million (2018-2023)
  • Table 112. United Kingdom Neurofeedback, by Component USD Million (2018-2023)
  • Table 113. United Kingdom Neurofeedback, by System USD Million (2018-2023)
  • Table 114. Netherlands Neurofeedback, by Type USD Million (2018-2023)
  • Table 115. Netherlands Neurofeedback, by Application USD Million (2018-2023)
  • Table 116. Netherlands Neurofeedback, by Function USD Million (2018-2023)
  • Table 117. Netherlands Neurofeedback, by Component USD Million (2018-2023)
  • Table 118. Netherlands Neurofeedback, by System USD Million (2018-2023)
  • Table 119. Rest of Europe Neurofeedback, by Type USD Million (2018-2023)
  • Table 120. Rest of Europe Neurofeedback, by Application USD Million (2018-2023)
  • Table 121. Rest of Europe Neurofeedback, by Function USD Million (2018-2023)
  • Table 122. Rest of Europe Neurofeedback, by Component USD Million (2018-2023)
  • Table 123. Rest of Europe Neurofeedback, by System USD Million (2018-2023)
  • Table 124. MEA Neurofeedback, by Country USD Million (2018-2023)
  • Table 125. MEA Neurofeedback, by Type USD Million (2018-2023)
  • Table 126. MEA Neurofeedback, by Application USD Million (2018-2023)
  • Table 127. MEA Neurofeedback, by Function USD Million (2018-2023)
  • Table 128. MEA Neurofeedback, by Component USD Million (2018-2023)
  • Table 129. MEA Neurofeedback, by System USD Million (2018-2023)
  • Table 130. Middle East Neurofeedback, by Type USD Million (2018-2023)
  • Table 131. Middle East Neurofeedback, by Application USD Million (2018-2023)
  • Table 132. Middle East Neurofeedback, by Function USD Million (2018-2023)
  • Table 133. Middle East Neurofeedback, by Component USD Million (2018-2023)
  • Table 134. Middle East Neurofeedback, by System USD Million (2018-2023)
  • Table 135. Africa Neurofeedback, by Type USD Million (2018-2023)
  • Table 136. Africa Neurofeedback, by Application USD Million (2018-2023)
  • Table 137. Africa Neurofeedback, by Function USD Million (2018-2023)
  • Table 138. Africa Neurofeedback, by Component USD Million (2018-2023)
  • Table 139. Africa Neurofeedback, by System USD Million (2018-2023)
  • Table 140. North America Neurofeedback, by Country USD Million (2018-2023)
  • Table 141. North America Neurofeedback, by Type USD Million (2018-2023)
  • Table 142. North America Neurofeedback, by Application USD Million (2018-2023)
  • Table 143. North America Neurofeedback, by Function USD Million (2018-2023)
  • Table 144. North America Neurofeedback, by Component USD Million (2018-2023)
  • Table 145. North America Neurofeedback, by System USD Million (2018-2023)
  • Table 146. United States Neurofeedback, by Type USD Million (2018-2023)
  • Table 147. United States Neurofeedback, by Application USD Million (2018-2023)
  • Table 148. United States Neurofeedback, by Function USD Million (2018-2023)
  • Table 149. United States Neurofeedback, by Component USD Million (2018-2023)
  • Table 150. United States Neurofeedback, by System USD Million (2018-2023)
  • Table 151. Canada Neurofeedback, by Type USD Million (2018-2023)
  • Table 152. Canada Neurofeedback, by Application USD Million (2018-2023)
  • Table 153. Canada Neurofeedback, by Function USD Million (2018-2023)
  • Table 154. Canada Neurofeedback, by Component USD Million (2018-2023)
  • Table 155. Canada Neurofeedback, by System USD Million (2018-2023)
  • Table 156. Mexico Neurofeedback, by Type USD Million (2018-2023)
  • Table 157. Mexico Neurofeedback, by Application USD Million (2018-2023)
  • Table 158. Mexico Neurofeedback, by Function USD Million (2018-2023)
  • Table 159. Mexico Neurofeedback, by Component USD Million (2018-2023)
  • Table 160. Mexico Neurofeedback, by System USD Million (2018-2023)
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Company Basic Information, Sales Area and Its Competitors
  • Table 172. Company Basic Information, Sales Area and Its Competitors
  • Table 173. Neurofeedback: by Type(USD Million)
  • Table 174. Neurofeedback Traditional Neurofeedback , by Region USD Million (2025-2030)
  • Table 175. Neurofeedback QEEG Loreta Neurofeedback , by Region USD Million (2025-2030)
  • Table 176. Neurofeedback: by Application(USD Million)
  • Table 177. Neurofeedback Neurocare Clinics , by Region USD Million (2025-2030)
  • Table 178. Neurofeedback Hospitals , by Region USD Million (2025-2030)
  • Table 179. Neurofeedback Training Institutes , by Region USD Million (2025-2030)
  • Table 180. Neurofeedback Scientific Research , by Region USD Million (2025-2030)
  • Table 181. Neurofeedback Others , by Region USD Million (2025-2030)
  • Table 182. Neurofeedback: by Function(USD Million)
  • Table 183. Neurofeedback Sleep Management , by Region USD Million (2025-2030)
  • Table 184. Neurofeedback Emotional Regulation , by Region USD Million (2025-2030)
  • Table 185. Neurofeedback Mental Fitness , by Region USD Million (2025-2030)
  • Table 186. Neurofeedback: by Component(USD Million)
  • Table 187. Neurofeedback EEG Sensor , by Region USD Million (2025-2030)
  • Table 188. Neurofeedback System , by Region USD Million (2025-2030)
  • Table 189. Neurofeedback Software , by Region USD Million (2025-2030)
  • Table 190. Neurofeedback: by System(USD Million)
  • Table 191. Neurofeedback Slow Cortical Potential Neurofeedback (SCP-NF) , by Region USD Million (2025-2030)
  • Table 192. Neurofeedback Low-energy Neurofeedback System (LENS) , by Region USD Million (2025-2030)
  • Table 193. Neurofeedback Hemoencephalographic (HEG) Neurofeedback , by Region USD Million (2025-2030)
  • Table 194. Neurofeedback Live Z-Score Neurofeedback System , by Region USD Million (2025-2030)
  • Table 195. Neurofeedback Low-Resolution Electromagnetic Tomography (LORE-TA) , by Region USD Million (2025-2030)
  • Table 196. Neurofeedback Functional Magnetic Resonance Imaging (fMRI) , by Region USD Million (2025-2030)
  • Table 197. Neurofeedback Other , by Region USD Million (2025-2030)
  • Table 198. South America Neurofeedback, by Country USD Million (2025-2030)
  • Table 199. South America Neurofeedback, by Type USD Million (2025-2030)
  • Table 200. South America Neurofeedback, by Application USD Million (2025-2030)
  • Table 201. South America Neurofeedback, by Function USD Million (2025-2030)
  • Table 202. South America Neurofeedback, by Component USD Million (2025-2030)
  • Table 203. South America Neurofeedback, by System USD Million (2025-2030)
  • Table 204. Brazil Neurofeedback, by Type USD Million (2025-2030)
  • Table 205. Brazil Neurofeedback, by Application USD Million (2025-2030)
  • Table 206. Brazil Neurofeedback, by Function USD Million (2025-2030)
  • Table 207. Brazil Neurofeedback, by Component USD Million (2025-2030)
  • Table 208. Brazil Neurofeedback, by System USD Million (2025-2030)
  • Table 209. Argentina Neurofeedback, by Type USD Million (2025-2030)
  • Table 210. Argentina Neurofeedback, by Application USD Million (2025-2030)
  • Table 211. Argentina Neurofeedback, by Function USD Million (2025-2030)
  • Table 212. Argentina Neurofeedback, by Component USD Million (2025-2030)
  • Table 213. Argentina Neurofeedback, by System USD Million (2025-2030)
  • Table 214. Rest of South America Neurofeedback, by Type USD Million (2025-2030)
  • Table 215. Rest of South America Neurofeedback, by Application USD Million (2025-2030)
  • Table 216. Rest of South America Neurofeedback, by Function USD Million (2025-2030)
  • Table 217. Rest of South America Neurofeedback, by Component USD Million (2025-2030)
  • Table 218. Rest of South America Neurofeedback, by System USD Million (2025-2030)
  • Table 219. Asia Pacific Neurofeedback, by Country USD Million (2025-2030)
  • Table 220. Asia Pacific Neurofeedback, by Type USD Million (2025-2030)
  • Table 221. Asia Pacific Neurofeedback, by Application USD Million (2025-2030)
  • Table 222. Asia Pacific Neurofeedback, by Function USD Million (2025-2030)
  • Table 223. Asia Pacific Neurofeedback, by Component USD Million (2025-2030)
  • Table 224. Asia Pacific Neurofeedback, by System USD Million (2025-2030)
  • Table 225. China Neurofeedback, by Type USD Million (2025-2030)
  • Table 226. China Neurofeedback, by Application USD Million (2025-2030)
  • Table 227. China Neurofeedback, by Function USD Million (2025-2030)
  • Table 228. China Neurofeedback, by Component USD Million (2025-2030)
  • Table 229. China Neurofeedback, by System USD Million (2025-2030)
  • Table 230. Japan Neurofeedback, by Type USD Million (2025-2030)
  • Table 231. Japan Neurofeedback, by Application USD Million (2025-2030)
  • Table 232. Japan Neurofeedback, by Function USD Million (2025-2030)
  • Table 233. Japan Neurofeedback, by Component USD Million (2025-2030)
  • Table 234. Japan Neurofeedback, by System USD Million (2025-2030)
  • Table 235. India Neurofeedback, by Type USD Million (2025-2030)
  • Table 236. India Neurofeedback, by Application USD Million (2025-2030)
  • Table 237. India Neurofeedback, by Function USD Million (2025-2030)
  • Table 238. India Neurofeedback, by Component USD Million (2025-2030)
  • Table 239. India Neurofeedback, by System USD Million (2025-2030)
  • Table 240. South Korea Neurofeedback, by Type USD Million (2025-2030)
  • Table 241. South Korea Neurofeedback, by Application USD Million (2025-2030)
  • Table 242. South Korea Neurofeedback, by Function USD Million (2025-2030)
  • Table 243. South Korea Neurofeedback, by Component USD Million (2025-2030)
  • Table 244. South Korea Neurofeedback, by System USD Million (2025-2030)
  • Table 245. Taiwan Neurofeedback, by Type USD Million (2025-2030)
  • Table 246. Taiwan Neurofeedback, by Application USD Million (2025-2030)
  • Table 247. Taiwan Neurofeedback, by Function USD Million (2025-2030)
  • Table 248. Taiwan Neurofeedback, by Component USD Million (2025-2030)
  • Table 249. Taiwan Neurofeedback, by System USD Million (2025-2030)
  • Table 250. Australia Neurofeedback, by Type USD Million (2025-2030)
  • Table 251. Australia Neurofeedback, by Application USD Million (2025-2030)
  • Table 252. Australia Neurofeedback, by Function USD Million (2025-2030)
  • Table 253. Australia Neurofeedback, by Component USD Million (2025-2030)
  • Table 254. Australia Neurofeedback, by System USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Neurofeedback, by Type USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Neurofeedback, by Application USD Million (2025-2030)
  • Table 257. Rest of Asia-Pacific Neurofeedback, by Function USD Million (2025-2030)
  • Table 258. Rest of Asia-Pacific Neurofeedback, by Component USD Million (2025-2030)
  • Table 259. Rest of Asia-Pacific Neurofeedback, by System USD Million (2025-2030)
  • Table 260. Europe Neurofeedback, by Country USD Million (2025-2030)
  • Table 261. Europe Neurofeedback, by Type USD Million (2025-2030)
  • Table 262. Europe Neurofeedback, by Application USD Million (2025-2030)
  • Table 263. Europe Neurofeedback, by Function USD Million (2025-2030)
  • Table 264. Europe Neurofeedback, by Component USD Million (2025-2030)
  • Table 265. Europe Neurofeedback, by System USD Million (2025-2030)
  • Table 266. Germany Neurofeedback, by Type USD Million (2025-2030)
  • Table 267. Germany Neurofeedback, by Application USD Million (2025-2030)
  • Table 268. Germany Neurofeedback, by Function USD Million (2025-2030)
  • Table 269. Germany Neurofeedback, by Component USD Million (2025-2030)
  • Table 270. Germany Neurofeedback, by System USD Million (2025-2030)
  • Table 271. France Neurofeedback, by Type USD Million (2025-2030)
  • Table 272. France Neurofeedback, by Application USD Million (2025-2030)
  • Table 273. France Neurofeedback, by Function USD Million (2025-2030)
  • Table 274. France Neurofeedback, by Component USD Million (2025-2030)
  • Table 275. France Neurofeedback, by System USD Million (2025-2030)
  • Table 276. Italy Neurofeedback, by Type USD Million (2025-2030)
  • Table 277. Italy Neurofeedback, by Application USD Million (2025-2030)
  • Table 278. Italy Neurofeedback, by Function USD Million (2025-2030)
  • Table 279. Italy Neurofeedback, by Component USD Million (2025-2030)
  • Table 280. Italy Neurofeedback, by System USD Million (2025-2030)
  • Table 281. United Kingdom Neurofeedback, by Type USD Million (2025-2030)
  • Table 282. United Kingdom Neurofeedback, by Application USD Million (2025-2030)
  • Table 283. United Kingdom Neurofeedback, by Function USD Million (2025-2030)
  • Table 284. United Kingdom Neurofeedback, by Component USD Million (2025-2030)
  • Table 285. United Kingdom Neurofeedback, by System USD Million (2025-2030)
  • Table 286. Netherlands Neurofeedback, by Type USD Million (2025-2030)
  • Table 287. Netherlands Neurofeedback, by Application USD Million (2025-2030)
  • Table 288. Netherlands Neurofeedback, by Function USD Million (2025-2030)
  • Table 289. Netherlands Neurofeedback, by Component USD Million (2025-2030)
  • Table 290. Netherlands Neurofeedback, by System USD Million (2025-2030)
  • Table 291. Rest of Europe Neurofeedback, by Type USD Million (2025-2030)
  • Table 292. Rest of Europe Neurofeedback, by Application USD Million (2025-2030)
  • Table 293. Rest of Europe Neurofeedback, by Function USD Million (2025-2030)
  • Table 294. Rest of Europe Neurofeedback, by Component USD Million (2025-2030)
  • Table 295. Rest of Europe Neurofeedback, by System USD Million (2025-2030)
  • Table 296. MEA Neurofeedback, by Country USD Million (2025-2030)
  • Table 297. MEA Neurofeedback, by Type USD Million (2025-2030)
  • Table 298. MEA Neurofeedback, by Application USD Million (2025-2030)
  • Table 299. MEA Neurofeedback, by Function USD Million (2025-2030)
  • Table 300. MEA Neurofeedback, by Component USD Million (2025-2030)
  • Table 301. MEA Neurofeedback, by System USD Million (2025-2030)
  • Table 302. Middle East Neurofeedback, by Type USD Million (2025-2030)
  • Table 303. Middle East Neurofeedback, by Application USD Million (2025-2030)
  • Table 304. Middle East Neurofeedback, by Function USD Million (2025-2030)
  • Table 305. Middle East Neurofeedback, by Component USD Million (2025-2030)
  • Table 306. Middle East Neurofeedback, by System USD Million (2025-2030)
  • Table 307. Africa Neurofeedback, by Type USD Million (2025-2030)
  • Table 308. Africa Neurofeedback, by Application USD Million (2025-2030)
  • Table 309. Africa Neurofeedback, by Function USD Million (2025-2030)
  • Table 310. Africa Neurofeedback, by Component USD Million (2025-2030)
  • Table 311. Africa Neurofeedback, by System USD Million (2025-2030)
  • Table 312. North America Neurofeedback, by Country USD Million (2025-2030)
  • Table 313. North America Neurofeedback, by Type USD Million (2025-2030)
  • Table 314. North America Neurofeedback, by Application USD Million (2025-2030)
  • Table 315. North America Neurofeedback, by Function USD Million (2025-2030)
  • Table 316. North America Neurofeedback, by Component USD Million (2025-2030)
  • Table 317. North America Neurofeedback, by System USD Million (2025-2030)
  • Table 318. United States Neurofeedback, by Type USD Million (2025-2030)
  • Table 319. United States Neurofeedback, by Application USD Million (2025-2030)
  • Table 320. United States Neurofeedback, by Function USD Million (2025-2030)
  • Table 321. United States Neurofeedback, by Component USD Million (2025-2030)
  • Table 322. United States Neurofeedback, by System USD Million (2025-2030)
  • Table 323. Canada Neurofeedback, by Type USD Million (2025-2030)
  • Table 324. Canada Neurofeedback, by Application USD Million (2025-2030)
  • Table 325. Canada Neurofeedback, by Function USD Million (2025-2030)
  • Table 326. Canada Neurofeedback, by Component USD Million (2025-2030)
  • Table 327. Canada Neurofeedback, by System USD Million (2025-2030)
  • Table 328. Mexico Neurofeedback, by Type USD Million (2025-2030)
  • Table 329. Mexico Neurofeedback, by Application USD Million (2025-2030)
  • Table 330. Mexico Neurofeedback, by Function USD Million (2025-2030)
  • Table 331. Mexico Neurofeedback, by Component USD Million (2025-2030)
  • Table 332. Mexico Neurofeedback, by System USD Million (2025-2030)
  • Table 333. Research Programs/Design for This Report
  • Table 334. Key Data Information from Secondary Sources
  • Table 335. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neurofeedback: by Type USD Million (2018-2023)
  • Figure 5. Global Neurofeedback: by Application USD Million (2018-2023)
  • Figure 6. Global Neurofeedback: by Function USD Million (2018-2023)
  • Figure 7. Global Neurofeedback: by Component USD Million (2018-2023)
  • Figure 8. Global Neurofeedback: by System USD Million (2018-2023)
  • Figure 9. South America Neurofeedback Share (%), by Country
  • Figure 10. Asia Pacific Neurofeedback Share (%), by Country
  • Figure 11. Europe Neurofeedback Share (%), by Country
  • Figure 12. MEA Neurofeedback Share (%), by Country
  • Figure 13. North America Neurofeedback Share (%), by Country
  • Figure 14. Global Neurofeedback share by Players 2023 (%)
  • Figure 15. Global Neurofeedback share by Players (Top 3) 2023(%)
  • Figure 16. Global Neurofeedback share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Neuro Care Group (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Neuro Care Group (Germany) Revenue: by Geography 2023
  • Figure 20. Myndlift Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 21. Myndlift Ltd (Israel) Revenue: by Geography 2023
  • Figure 22. Brainmaster Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Brainmaster Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 24. Mitsar Co. Ltd (Russia) Revenue, Net Income and Gross profit
  • Figure 25. Mitsar Co. Ltd (Russia) Revenue: by Geography 2023
  • Figure 26. Emotiv Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Emotiv Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Brainworks (United States) Revenue, Net Income and Gross profit
  • Figure 29. Brainworks (United States) Revenue: by Geography 2023
  • Figure 30. Mindfield Biosystems Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Mindfield Biosystems Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 32. Narbis (United States) Revenue, Net Income and Gross profit
  • Figure 33. Narbis (United States) Revenue: by Geography 2023
  • Figure 34. Thought Technology Ltd. (Canada) Revenue, Net Income and Gross profit
  • Figure 35. Thought Technology Ltd. (Canada) Revenue: by Geography 2023
  • Figure 36. InteraXon Inc. (Muse) (Canada) Revenue, Net Income and Gross profit
  • Figure 37. InteraXon Inc. (Muse) (Canada) Revenue: by Geography 2023
  • Figure 38. Mind Media (Netherlands) Revenue, Net Income and Gross profit
  • Figure 39. Mind Media (Netherlands) Revenue: by Geography 2023
  • Figure 40. NeuralScan (United States) Revenue, Net Income and Gross profit
  • Figure 41. NeuralScan (United States) Revenue: by Geography 2023
  • Figure 42. Global Neurofeedback: by Type USD Million (2025-2030)
  • Figure 43. Global Neurofeedback: by Application USD Million (2025-2030)
  • Figure 44. Global Neurofeedback: by Function USD Million (2025-2030)
  • Figure 45. Global Neurofeedback: by Component USD Million (2025-2030)
  • Figure 46. Global Neurofeedback: by System USD Million (2025-2030)
  • Figure 47. South America Neurofeedback Share (%), by Country
  • Figure 48. Asia Pacific Neurofeedback Share (%), by Country
  • Figure 49. Europe Neurofeedback Share (%), by Country
  • Figure 50. MEA Neurofeedback Share (%), by Country
  • Figure 51. North America Neurofeedback Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Neuro Care Group (Germany)
  • Myndlift Ltd (Israel)
  • Brainmaster Technologies, Inc. (United States)
  • Mitsar Co. Ltd (Russia)
  • Emotiv Inc. (United States)
  • Brainworks (United States)
  • Mindfield Biosystems Ltd. (United Kingdom)
  • Narbis (United States)
  • Thought Technology Ltd. (Canada)
  • InteraXon Inc. (Muse) (Canada)
  • Mind Media (Netherlands)
  • NeuralScan (United States)
Additional players considered in the study are as follows:
Wearable Sensing (United States) , Stens Corporation (United States) , BEE Medic (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 224 Pages 58 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Neurofeedback Market Quantitative research analysis
Global Neurofeedback Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Neurofeedback Market are by type [Traditional Neurofeedback and QEEG Loreta Neurofeedback], by end use application [Neurocare Clinics, Hospitals, Training Institutes, Scientific Research and Others].
The Neurofeedback Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing prevalence of anxiety, ADHD, and depression in people across the world leading to other problems like insomnia. It needs to be managed, regulated for emotional wellbeing resulting in better sleep management.

Know More About Global Neurofeedback Market Report?

Have a Query? Click Here

Other Related Reports

Advanced (3D/4D) Visualization Systems Comprehensive Study by Application (Cardiology, Neurology, Oncology, Other), Platform (Ultrasound AVS, Magnetic Resonance Imaging AVS, Computed Tomography AVS, ...
$ 3650
Prenatal Screening Test Comprehensive Study by Type (Screening Tests (Blood Test, Ultrasound Test), Diagnostic Tests (Amniocentesis Test, Chorionic Villus Sampling Test)), Test Stages (First Trimeste...
$ 3750
Oncology Ablation Comprehensive Study by Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)), Application (Liver Cancer, Kidney ...
$ 3800
Clinical Data Analytics in Healthcare Comprehensive Study by Type (Software, Services), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and...
$ 3750
Test Tube Baby Comprehensive Study by Type (Reagents (Embryo culture media, Cryopreservation media, Sperm processing media, Ovum processing media), Equipment (Imaging system, Sperm separation system,...
$ 3750
Medical Laser Technology Comprehensive Study by Type (Solid state laser system, Diode laser system, Dye laser system, Gas laser system), Application (Diagnostic, Surgical, Cosmetic, Therapeutic, Dent...
$ 3800